Reference No.

: - 2505019663 Age/Gender : 25 Yrs/Female

Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:22PM Approved Date :10-May-2025 06:28PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

WHOLE BODY PROFILE

BIOCHEMISTRY
Test Description Observed Value Biological Reference Interval
Blood Sugar Fasting, Fluoride plasma 79.3 F - 70 - 110
Hexokinase
PP - 90 - 130 mg/dL,

R -80 - 140 mg/dL mg/dL

Interpretation (In accordance with the American diabetes association guidelines):
· A fasting plasma glucose level below 100 mg/dL is considered normal.
· A fasting plasma glucose level between 100-126 mg/dL is considered as glucose intolerant or pre diabetic. A fasting and post-prandial blood sugar test (after
consumption of 75 gm of glucose) is recommended for all such patients.
· A fasting plasma glucose level of above 126 mg/dL is highly suggestive of a diabetic state. A repeat fasting test is strongly recommended for all such patients. A
fasting plasma glucose level in excess of 126 mg/dL on both the occasions is confirmatory of a diabetic state.

*** End Of Report ***

Page 1 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:20PM Approved Date :10-May-2025 06:39PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Test Description Observed Value Biological Reference Interval

LIVER FUNCTION TEST (LFT), Serum
Bilirubin, Total 0.80 Adults : 0.0-1.3 mg/dL
(Colorimetric diazomethod) Child(>1months):0.0-1.3 mg/dL
Bilirubin, Direct 0.20 0 - 0.4 mg/dL
Calculated
Bilirubin, Indirect 0.60 0.0 - 0.80 mg/dL
Diazonium method
SGOT (AST), Serum 22.00 14 - 36 U/L
UV with P-5-P
SGPT (ALT), Serum 14.00 1-35 U/L
UV with P-5-P
Alkaline Phosphatase (ALP), Serum 117.0 38 - 126 U/L
PNPP AMP
Gamma Glutamyl Transferase (GGT)* 28 12-43 U/L
G-glutamyl p nitroanilide
Protein,Total 7.70 6.3-8.2 g/dL
Biuret Method
Albumin,Serum 4.30 Adults:3.5-5.2
Bromo Cresol Green Method Newborn 0-4 days:2.8-4.4
Children 4 days-14 yr:3.8-5.4
14-18 years : 3.2-4.5 g/dL
Globulin 3.40 2.30-3.50 g/dL
Calculated
A/G Ratio 1.26
Equipment Used: VITROS® XT 7600 Integrated System [Dry Chemistry]
Equipment measurement : Colorimetric/Rate,Potentiometric (Direct ISEs),Immuno-rate,Turbidimetric,Enhanced Chemiluminescence
COMMENT : Please correlate with clinical conditions and drug history. This report is not valid for medico legal purpose.
If the results of the tests are alarming or unexpected, please contact immediately

*** End Of Report ***

Page 2 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:20PM Approved Date :10-May-2025 06:39PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Test Description Observed Value Biological Reference Interval

LIPID PROFILE, Serum
Triglyceride 150.0 0.0 - 150 mg/dL
GPO-PAP
Total Cholesterol 159.0 Desirable: 200
Enzymatic, Oxidase estrase peroxidase Borderline: 201-240
High: >240 mg/dL
HDL Cholesterol 62.0 40-60 mg/dL
Direct measure, PTA and MgCl2
VLDL Cholesterol 30.0 15.0 - 40.0 mg/dL
Calculated
LDL Cholesterol 67.0 Optimal: < 100
Calculated Near optimal: 100-129
Borderline high: 130-159
High: 160-189
Very high: >190 mg/dL
Total / HDL Cholesterol Ratio 2.6 3.0 - 6.0 Ratio
Calculated
LDL / HDL Cholestrol Ratio 1.08 0.00 - 3.55 Ratio
Calculated
Equipment Used: VITROS® XT 7600 Integrated System [Dry Chemistry]
Equipment measurement : Colorimetric/Rate,Potentiometric (Direct ISEs),Immuno-rate,Turbidimetric,Enhanced Chemiluminescence

COMMENT :
Tests results are created by fully/semi automated equipments.
This is only a professional opinion, not the diagnosis.
Please correlate with clinical conditions and drug history.
This report is not valid for medico legal purpose.
If the results of the tests are alarming or unexpected, please contact immediately.

*** End Of Report ***

Page 3 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:20PM Approved Date :10-May-2025 06:39PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Test Description Observed Value Biological Reference Interval

Kidney Profile, Serum
Urea 20.00 14.98-36.38 mg/dL
Kinetic test with urease and GLDH
Creatinine 0.90 0.52-1.04 mg/dL
Enzymatic, IFCC-IDMS
Uric Acid, Serum 5.00 2.5-6.2 mg/dL
Uricase
Protein, Total 7.70 6.30-8.20 g/dL
Biuret
Sodium 139.90 137.0-145.0 mmoL
Direct Ion-Selective Electrode (DISE)
Potassium 5.00 3.50-5.10 mmol/L
Direct Ion-Selective Electrode (DISE)
Chloride 101.0 98 - 107 mmol/L
Direct Ion-Selective Electrode (DISE)
Calcium, Serum 9.10 8.4-10.2 mg/dL
Arsenazo III
Equipment Used: VITROS® XT 7600 Integrated System [Dry Chemistry]
Equipment measurement : Colorimetric/Rate,Potentiometric (Direct ISEs),Immuno-rate,Turbidimetric,Enhanced Chemiluminescence

COMMENT :
Tests results are created by fully/semi automated equipments.
This is only a professional opinion, not the diagnosis.
Please correlate with clinical conditions and drug history.
This report is not valid for medico legal purpose.
If the results of the tests are alarming or unexpected, please contact immediately.

*** End Of Report ***

Page 4 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:20PM Approved Date :10-May-2025 06:39PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Test Description Observed Value Biological Reference Interval

IRON TIBC, Serum
Iron, Serum 72.50 37-170 ug/dL
FerroZine method without deproteinization
Unsaturated Iron Binding Capacity, Serum 309.80 120-470 ug/dL
Direct determination with FerroZine
Total Iron​ Binding capacity, Serum 382.30 155 - 638 ug/dL
Calculated
Total iron-binding capacity
The test measures the extent to which iron-binding sites in the serum can be saturated. Because the iron-binding sites in the serum are almost entirely
dependent on circulating transferrin, this is really an indirect measurement of the amount of transferrin in the blood.
Taken together with serum iron and percent transferrin saturation clinicians usually perform this test when they are concerned about anemia, iron deficiency
or iron deficiency anemia. However, because the liver produces transferrin, liver function must be considered when performing this test. It can also be an
indirect test of liver function, but is rarely used for this purpose.

Comment :
Tests results are created by fully/semi automated equipments.
This is only a professional opinion, not the diagnosis.
Please correlate with clinical conditions and drug history.
This report is not valid for medico legal purpose.
If the results of the tests are alarming or unexpected, please contact immediately

*** End Of Report ***

Page 5 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:27PM Approved Date :10-May-2025 07:14PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

MICROSCOPY
Test Description Observed Value Biological Reference Interval
URINE EXAMINATION ROUTINE*
Physical Examination
Volume 20.00 - mL
Naked Eye
Colour PALE YELLOW Transparent
Naked Eye
Appearance CLEAR Clear
Naked Eye
pH 6.00 4.6-8.0
Double Indicator
Specific Gravity 1.010 1.005-1.030
Pre-treated polymeric ion exchange resin
Chemical Examination
Urine Protein.. NIL NIL
Tetra bromophenol blue/Sulphosalicylic Acid
Urine Sugar NIL
Glucose oxidase peroxidase chromogen reaction
Microscopic Examination
R.B.C. NIL NIL /HPF
Pus Cells 1-2 0-5 /HPF
Epithelial Cells 2-4 0-3 /HPF
Casts NIL Nil /LPF
Crystals* NIL Nil
Bacteria* NIL Nil

*** End Of Report ***

Page 6 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:39PM Approved Date :10-May-2025 06:17PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

HAEMATOLOGY
Test Description Observed Value Biological Reference Interval
Complete Blood Count*[6 part Sysmex XN-550], EDTA whole blood
Haemoglobin (Hb)* 12.8 12.0-16.0 g/dL
RBC Count* 4.10 4.00-5.20 Millions/cumm
Packed Cell Volume* 45.0 36-46 %
MCV* 109.8 80-100 fL
MCH* 31.2 26-34 pg
MCHC* 28.4 31-37 g/dL
RDW-CV* 15.5 11.5-14.5 %
TLC (Total Leucocyte Count)* 8510 4000-11000 /cumm
Differential Leucocyte Count
Neutrophil* 64.5 40-80 %
Lymphocyte* 27.6 24-44 %
Eosinophils* 2.7 01-06 %
Monocytes* 4.6 2-8 %
Basophils* 0.6 0-1 %
IG %* 0.200 0.0 - 0.40 %
Absolute Neutrophil Count* 5.49 2.0-7.0 x 10^3 /uL
Absolute Lymphocyte Count* 2.350 1.0-3.0 x 10^3/uL
Absolute Eosinophil Count* 0.230 0.02-0.50 10^3/uL
Absolute Monocyte Count* 0.4 0.2-1.0 x 10^3/uL
Absolute Basophil Count* 0.050 0.02-0.10 x 10^3 cells/uL
IG* 0.000 0.0 -0.30 10^3/uL
Platelet Count* 1.70 1.50-4.50 Lakh/cumm
Mean Platelet Volume* 14.10
Plateletcrit* 0.20 0.20 - 0.50 %
PDW [Platelet Distribution Width]* 23.00 09 - 17 fL
P-LCR [Platelet to Large Cell Ratio]* 55.40 19.7 - 42.4 %
Interpretation :
Causes of low Hb include: Causes of high Hb include:

Page 7 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:39PM Approved Date :10-May-2025 06:17PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Iron deficiency anemia, Vitamin deficiency anemia. (B12/Folic

Smoking, COPD (chronic obstructive pulmonary disease)exacerbation,
acid),Anemia of inflammation, Aplastic anemia, Anemias associated with
Dehydration, Emphysema, Heart failure,Polycythemia vera
bone marrow disease, Hemolytic anemia etc
Causes of low WBC include: Causes of high WBC include:
Cancer (caused by chemotherapy treatments),Bone marrow disorders or
damage, Autoimmune disorders (problems with the immune system in Infection, Inflammation, Injury, Emotional stress, Labor,
which the body attacks itself), such as lupus, Infections (including Pregnancy,Smoking, Allergic reactions, Excessive exercise, A bone
tuberculosis and HIV),Immune system conditions, Crohn’s disease, marrow or immune disorder, Certain cancers, such as acute or chronic
Malnutrition, Radiation treatments for cancer, Rheumatoid arthritis, leukemia
Vitamin deficiencies, Liver damage and/or enlarged spleen.
Causes of low Platelets include: Causes of high Platelets include:
Acute bleeding and blood loss, Cancer, Infections, Iron
Leukemia and other cancers, Some types of anemia., Viral infections
deficiency,Removal of your spleen, Inflammatory disorders, such as
such as Dengue, Hepatitis C or HIV, Chemotherapy drugs and radiation
rheumatoid arthritis, sarcoidosis or inflammatory bowel disease, Surgery
therapy, Heavy alcohol consumption, ITP
or other type of trauma, Essential thrombocythemia

Please Correlate with clinical conditions.

Instrument : Fully automated bidirectional hematology analyser (6 part differential Sysmex XN-550)
Method : Hematology analyses according to the Hydrodynamic Focussing [DC method],
Flow Cytometry Method [Using a semiconductor laser], and SLS- hemoglobin method.
Sample : EDTA whole blood in cool condition

*** End Of Report ***

Page 8 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:39PM Approved Date :10-May-2025 06:04PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Test Description Observed Value Biological Reference Interval

HbA1c (Glycated Haemoglobin), EDTA Plasma 5.2 4.5-6.4 %
High Pressure Liquid Chromatograpy
REMARKS
In vitro quantitative determination of HbA1c in whole blood is utilized in long term monitoring of glycemia.The HbA1c level correlates with the mean glucose concentration prevailing in
the course of the patient's recent history (approx - 6-8 weeks) and therefore provides much more reliable information for glycemia monitoring than do determinations of blood glucose or
urinary glucose. It is recommended that the determination of HbA1c be performed at intervals of 4-6 weeks during Diabetes Mellitus therapy. Results of HbA1c should be assessed in
conjunction with the patient's medical history, clinical examinations and other findings.
Mean Plasma Glucose, EDTA Plasma 102.54 mg/dL
Calculated
Mean Plasma Glucose is based on estimated Average Glucose (eAG) value calculated according to National Glycohemoglobin Standardization Program (NGSP) criteria.

Reference Range (HBA1c) :

Good control : 4.5 - 6.4 %
Fair control : 6.5 - 7.4 %
Poor control : Above - 7.5 %

Reference Range (Average Blood Sugar):

Excellent control : 90 - 120 mg/dl

Good control : 121 - 150 mg/dl
Average control : 151 - 180 mg/dl
Action suggested : 181 - 210 mg/dl
Panic value : > 211 mg/dl

[Note: Average blood sugar values is calculated from hba1c value and it indicates average blood sugar level over past three months.]

*** End Of Report ***

Page 9 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:20PM Approved Date :10-May-2025 06:43PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

IMMUNOASSAY
Test Description Observed Value Biological Reference Interval
T3 T4 TSH,Serum
Triiodothyronine, Total (T3), Serum 161 60-181 ng/dL
Chemiluminescence Immuno Assay
Thyroxine, Total (T4), Serum 9.6 4.5-10.9 ug/dL
Chemiluminescence Immuno Assay
3rd Gen. ( TSH Ultrasensitive ),Serum 3.10 0.35-5.50 ulU/mL
Chemiluminescence Immuno Assay
COMMENT :
The levels of thyroid hormone (T3 & T4) Are Low In case of Primary, secondary and tertiary hypothyroidism and sometimes in non-thyroidal illness also.
Increased levels are found in grave’s disease, hyperthyroidism and thyroid hormone resistance. T3 levels are also raised in T3 thyrotoxicosis. TSH levels are raised
in primary hypothyroidism and are low in hyperthyroidism and secondary hypothyroidism.

In Pregnancy:

LEVEL TOTAL T3 TOTAL T4 TSH

Ist Trimester 81-190 6.6-12.4 0.1-2.5
IInd Trimester 100-260 6.6-15.5 0.2-3.0
IIIrd Trimester 100-260 6.6-15.5 0.3-3.0

*** End Of Report ***

Page 10 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:20PM Approved Date :10-May-2025 06:43PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Test Description Observed Value Biological Reference Interval

Vitamin D 25-Hydroxy (VIT-D), Serum
Vitamin D, 25 Hydroxy, Serum 10.8 20-100 ng/mL
Chemiluminescence Immuno Assay
Reference Range
Deficiency < 20 ng/mL
Insufficiency 20-30 ng/mL
Sufficiency 30-100 ng/mL
Toxicity >100 ng/mL

Comments
Cholecalciferol (Vitamin D3) is synthesized in the skin from 7 dehydrocholesterol in response to sunlight; some part also comes from diet and supplements.
Ergocalciferol (vitamin D2) comes essentially from diet and supplements. Both cholecalciferol and ergocalciferol are converted in liver to 25 OH Vitamin D which is
considered the best indicator of Vitamin D nutritional status. Vitamin D toxicity is recognized, but is a rare occurrence.
Kindly correlate all result clinically.

*** End Of Report ***

Page 11 of 12
Please scan the QR code to authenticate the report.
 Reference No. : - 2505019663 Age/Gender : 25 Yrs/Female
Pt's Name : Miss. URVASHI
DHJ-SANDIP
Referred By : NA
Sample Collection Date/Time : 10-May-2025 Date :10-May-2025
Sample Receiving Date/Time : 10-May-2025 05:20PM Approved Date :10-May-2025 07:20PM
Sample From : DR SANDIP KHANNA Report Print Time :10-May-2025 08:24PM

Test Description Observed Value Biological Reference Interval

Vitamin B12 (Cyanocobalamin),Serum
Vitamin B12 Level, Serum 252 211.0-911.0 pg/mL
Chemiluminescence Immuno Assay
Comments
Vitamin B12 along with folate is essential for DNA synthesis and myelin formation. Vitamin B12 deficiency can be because of nutritional deficiency, malabsorption
and other gastrointestinal causes. The test is ordered primarily to help diagnose the cause of macrocytic/ megaloblastic anemia .

Decreased levels are seen in: Increased levels are seen in:
Anaemia, normal near term pregnancy, vegetarianism, Renal failure, hepatocelluar disorders,
partial gastrectomy/ileal damage, celiac disease, with myeloproliferative disorders and at times with excess
oral contraceptive use, parasitic competition, pancreatic supplementation of vitamins pills.
deficiency, treated epilepsy, smoking, hemodialysis and
advancing age.

*** End Of Report ***

Page 12 of 12
Please scan the QR code to authenticate the report.